by Microarray Market size is expected to grow Usd 8.15 bn by 2030 at a CAGR of 8.2% over the forecast period 2021 – 2030.
A new study on the global Microarray market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global Microarray market. The study offers valuable information about the global Microarray market to illustrate how the market would grow during the forecast period 2021-2030. The report provides the value and volume of the global Microarray market for the period 2021–2030, considering 2019 as the base year and 2030 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global Microarray market during the forecast period.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1201
An extensive analysis on business strategies of leading market players is also featured in study on the global Microarray market. This can help readers understand principal factors to foresee growth in the global Microarray market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global Microarray market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Players
- Illumina, Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Merck & Co., Inc.
- PerkinElmer, Inc.
- Arrayit Corporation
- Bio-Rad Laboratories
- GE Healthcare
- Molecular Devices, LLC
- Affymetrix
Key Questions Answered in Microarray Market Study
– What are the key factors influencing the Microarray market in each region?
– What will be the CAGR of the global Microarray market between 2017 and 2030?
– What is the future scope and changing trends in technologies in the global Microarray market?
– Which factors will impede the growth of the global Microarray market during the forecast period?
– Which are the leading companies in the global Microarray market?
– Which region is set to expand at the fastest CAGR during the forecast period?
– What is the volume (Units) of different Microarray across all regions during the forecast period?
– Which segment will have the highest revenue globally in 2030 and which segment will expand at the fastest CAGR during the forecast period?
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1201
Research Methodology
A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global Microarray market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global Microarray market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from Microarray industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.
Segmentation
By Product
- Consumables
- Software & Services
- Instruments
By Type
- DNA Microarrays
- Protein Microarrays
- Other Microarrays
By Application
- Agriculture
- Research Applications
- Drug Discovery
- Diseases Diagnostics
- Other Applications
By End User
- Research & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Other End Users
- Others
By Geography
- North America
-
-
- U.S.
- Canada
-
- Europe
-
-
- Germany
- France
- United Kingdom
- Rest of Europe
-
- Asia Pacific
-
-
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
-
- Latin America
-
-
- Brazil
- Rest of Latin America
-
- Middle East & Africa (MEA)
-
-
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
-
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Microarray Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Microarray Market
5.1. Covid-19: Microarray Industry Impact
5.2. Microarray Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Microarray Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Microarray Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Microarray Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing incidence of cancer worldwide
6.1.1.2. Increasing expenditure on research and development in the healthcare sector
6.1.2. Market Restraints
6.1.2.1. Stringent Regulations
6.1.3. Market Opportunities
6.1.3.1. Growing awareness regarding personalized medicines
6.1.3.2. Increasing preference for DNA based microarrays
Chapter 7. Global Microarray Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Microarray Market Revenue by Market Players (2016 -2019)
7.1.1.2. MicroarrayMarket Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Microarray Market, By Product
8.1. Microarray Market, by Product, 2017-2030
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Software & Services
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Instruments
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Microarray Market, By Type
9.1. Microarray Market, by Type, 2017-2030
9.1.1. DNA Microarrays
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Protein Microarrays
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Other Microarrays
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Microarray Market, By Application
10.1. Microarray Market, by Application, 2017-2030
10.1.1. Agriculture
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Research Applications
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Drug Discovery
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Diseases Diagnostics
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Other Applications
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Microarray Market, By End User
11.1. Microarray Market, by End User, 2017-2030
11.1.1. Research & Academic Institutes
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceutical & Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Diagnostic Laboratories
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Other End Users
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Microarray Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Product(2017-2030)
12.1.2. Market Revenue Forecast by Type(2017-2030)
12.1.3. Market Revenue Forecast by Application (2017-2030)
12.1.4. Market Revenue Forecast by End User (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2017-2030)
12.2.2. Market Revenue Forecast by Type (2017-2030)
12.2.3. Market Revenue Forecast by Application (2017-2030)
12.2.4. Market Revenue Forecast by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2017-2030)
12.3.2. Market Revenue Forecast by Type (2017-2030)
12.3.3. Market Revenue Forecast by Application (2017-2030)
12.3.4. Market Revenue Forecast by End User (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2017-2030)
12.4.2. Market Revenue Forecast by Type (2017-2030)
12.4.3. Market Revenue Forecast by Application (2017-2030)
12.4.4. Market Revenue Forecast by End User (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2017-2030)
12.5.2. Market Revenue Forecast by Type (2017-2030)
12.5.3. Market Revenue Forecast by Application (2017-2030)
12.5.4. Market Revenue Forecast by End User (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)
Chapter 13. Company Profiles
13.1. Illumina, Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2015-2020)
13.1.4. Recent Developments and Strategies
13.2. Agilent Technologies, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2015-2020)
13.2.4. Recent Developments and Strategies
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2015-2020)
13.3.4. Recent Developments and Strategies
13.4. Merck & Co., Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2015-2020)
13.4.4. Recent Developments and Strategies
13.5. PerkinElmer, Inc.
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2015-2020)
13.5.4. Recent Developments and Strategies
13.6. Arrayit Corporation
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2015-2020)
13.6.4. Recent Developments and Strategies
13.7. Bio-Rad Laboratories
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2015-2020)
13.7.4. Recent Developments and Strategies
13.8. GE Healthcare
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2015-2020)
13.8.4. Recent Developments and Strategies
13.9. Molecular Devices, LLC
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2015-2020)
13.9.4. Recent Developments and Strategies
13.10. Affymetrix
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2015-2020)
13.10.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/1201
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
